BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,079 filers reported holding BAXTER INTL INC in Q3 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,833,026 | -18.1% | 1,028,962 | -1.2% | 0.34% | -13.9% |
| Q2 2023 | $47,440,398 | -30.0% | 1,041,273 | -37.6% | 0.40% | +44.7% |
| Q1 2023 | $67,736,254 | +79.5% | 1,670,026 | +125.6% | 0.27% | -7.5% |
| Q4 2022 | $37,736,710 | +155.6% | 740,371 | +331.8% | 0.30% | +95.4% |
| Q2 2020 | $14,764,000 | +15.9% | 171,474 | +9.3% | 0.15% | -0.7% |
| Q1 2020 | $12,742,000 | -10.2% | 156,938 | -5.1% | 0.15% | +52.0% |
| Q4 2019 | $14,195,000 | -3.6% | 165,302 | -1.8% | 0.10% | -7.4% |
| Q3 2019 | $14,729,000 | +6.3% | 168,381 | -0.5% | 0.11% | +12.5% |
| Q2 2019 | $13,855,000 | +9.3% | 169,169 | +8.5% | 0.10% | +9.1% |
| Q1 2019 | $12,675,000 | -13.2% | 155,878 | -29.7% | 0.09% | -18.5% |
| Q4 2018 | $14,603,000 | -12.4% | 221,850 | +2.7% | 0.11% | +3.8% |
| Q3 2018 | $16,661,000 | -5.8% | 216,114 | -9.8% | 0.10% | -8.0% |
| Q2 2018 | $17,689,000 | +12.2% | 239,552 | -1.1% | 0.11% | +14.1% |
| Q1 2018 | $15,759,000 | -3.5% | 242,293 | -4.1% | 0.10% | +1.0% |
| Q4 2017 | $16,336,000 | +0.6% | 252,722 | -2.3% | 0.10% | -4.9% |
| Q3 2017 | $16,237,000 | +10.7% | 258,748 | +6.8% | 0.10% | +9.6% |
| Q2 2017 | $14,670,000 | +16.8% | 242,315 | +0.0% | 0.09% | +19.0% |
| Q1 2017 | $12,563,000 | +17.1% | 242,230 | +0.1% | 0.08% | +16.2% |
| Q4 2016 | $10,733,000 | +47.8% | 242,059 | +58.6% | 0.07% | +41.7% |
| Q3 2016 | $7,264,000 | +115.9% | 152,600 | +105.2% | 0.05% | +108.7% |
| Q2 2016 | $3,364,000 | -74.8% | 74,374 | -77.1% | 0.02% | -73.6% |
| Q1 2016 | $13,342,000 | +6.5% | 324,779 | -1.1% | 0.09% | +8.8% |
| Q4 2015 | $12,528,000 | +15.9% | 328,379 | -0.2% | 0.08% | +14.3% |
| Q3 2015 | $10,807,000 | -44.0% | 328,967 | +19.3% | 0.07% | -42.1% |
| Q2 2015 | $19,281,000 | +5.6% | 275,710 | +3.4% | 0.12% | +2.5% |
| Q1 2015 | $18,263,000 | +26.1% | 266,610 | +35.0% | 0.12% | +21.6% |
| Q4 2014 | $14,478,000 | +28.4% | 197,540 | +25.7% | 0.10% | +16.9% |
| Q3 2014 | $11,275,000 | +90.9% | 157,090 | +92.3% | 0.08% | +80.4% |
| Q2 2014 | $5,907,000 | -63.0% | 81,690 | -64.5% | 0.05% | -72.0% |
| Q2 2013 | $15,946,000 | – | 230,190 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |